Health & Medical · Week of Oct 26, 2026
FDA milestones for AI imaging and neuro devices: the week in health
Device makers report regulatory milestones and executive hires, alongside new consumer wellness and skincare launches and a study on family well-being.
Medical device news led the week. Perimeter Medical Imaging AI says its Claire imaging system, which it describes as the first FDA-approved, AI-enabled device in the U.S. for intraoperative breast cancer margin assessment, received a TIME Best Inventions of 2026 special mention. Pharaoh Neuro says the FDA granted Breakthrough Device Designation to its Neurapheresis CSF Management System for use following aneurysmal subarachnoid hemorrhage. Accuray and TransMedics both filed Nasdaq-required notices of equity inducement awards on Oct. 30, 2026.
On the consumer side, Canyon Ranch opened a 40,000-square-foot spa at its Austin resort, and Face Reality launched a retinoid serum for adults with both acne and signs of aging. Keio University reported research on how happiness and health are linked across generations in Japanese families. Millennium Dental Technologies and the Institute for Advanced Laser Dentistry announced the death of Professor Raymond A. Yukna.

Perimeter Medical Imaging AI Inc.
Perimeter Medical's Claire™ Earns TIME Best Inventions of 2026 Special Mention and Multiple Industry Honors
Perimeter Medical Imaging AI says its Claire device earned a TIME Best Inventions of 2026 special mention and other industry honors, following FDA approval and a first U.S. commercial deployment at Intermountain Health. The company describes Claire as the first FDA-approved, AI-enabled imaging device in the U.S. for intraoperative breast cancer margin assessment.

Accuray Incorporated
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
Accuray Incorporated reported equity inducement awards on Oct. 30, 2026, to Sofiane Laoussadi, its new Senior Vice President, Global Services & Solutions, as required by NASDAQ Listing Rules. The filing marks a senior hire in the company's global services organization.

TransMedics Group, Inc.
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group said that on October 28, 2026, it made inducement grants under NASDAQ Listing Rule 5635(c)(4). The company describes itself as developing organ transplant therapy for patients with end-stage lung, heart and liver failure.

Canyon Ranch
Inside Canyon Ranch Austin: A First Look at the Future of Wellness
Canyon Ranch says the spa at its Canyon Ranch Austin resort in Texas Hill Country is now open, in a 40,000-square-foot facility it calls the largest spa in Texas. The company says the facility pairs traditional spa treatments with beauty and recovery services.
Keio University
Keio University Research: Study Reveals How Happiness and Health are Linked across Generations
Keio University reported an analysis of Japanese families which found that happiness shows a stronger parent–child connection than general or mental health. The researchers say well-being is less closely tied across generations than income.

Face Reality
FACE REALITY, A LEADING ACNE AUTHORITY, INTRODUCES AGE ADAPTIVE CLEARING SERUM -- A CLINICALLY TESTED RETINOID INNOVATION FOR ACNE-PRONE, AGING SKIN
Face Reality Skincare introduced Age Adaptive Clearing Serum, which it describes as a clinically tested retinoid product for acne-prone, aging skin. The company says the product is designed to address acne and aging together rather than one at a time.

Millennium Dental Technologies, Inc.
Millennium Dental Technologies and Institute for Advanced Laser Dentistry Mourn Passing of Professor Raymond A. Yukna, DMD, MS (1942-2026)
Millennium Dental Technologies and the Institute for Advanced Laser Dentistry announced the death of Professor Raymond A. Yukna, DMD, MS (1942-2026). The organizations describe him as a clinician, educator, researcher and mentor.

Pharaoh Neuro
FDA Grants Breakthrough Device Designation to Pharaoh Neuro's Neurapheresis™ CSF Management System
Pharaoh Neuro says the FDA granted Breakthrough Device Designation to its Neurapheresis CSF Management System. According to the company, the designation recognizes the system's potential to offer advantages over existing treatment options following aneurysmal subarachnoid hemorrhage (aSAH).
This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not Elle Digest reporting.